Compare TeraWulf Inc (WULF) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TeraWulf Inc vs Zoetis Inc — how do they compare? TeraWulf Inc trades at $13.81 (market cap $6.81B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 4.4× TeraWulf Inc's market cap, and Zoetis Inc pays a 2.9% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TeraWulf Inc for 17 Days and Zoetis Inc for 70 Days on average.
| WULF | ZTS | |
|---|---|---|
Market Cap | $6.81B | $30.20B |
Volume | 45,841,998 | 6,175,327 |
Sector | Financials | Health |
52-Week High | $28.98 | $147.53 |
52-Week Low | $10.99 | $69.09 |
Typical Hold Time | 17 Days | 70 Days |
Enterprise Value | $9.43B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TeraWulf (WULF) trades at $13.77, down 4.38% on the day, amid a bearish technical signal and weak fundamentals. The company reported a net loss of $661.42 million in 2025 with a negative net income margin of -1,179.94%, while revenue was $168.46 million. Recent news highlights volatility tied to AI infrastructure trends, with shares reacting to sector-wide moves and analyst coverage initiations.
Despite unanimous analyst buy ratings and a $34.92 consensus price target implying significant upside, high valuation ratios and persistent losses pose substantial risks. Investment appeal hinges on successful execution of the AI data center strategy, but cash flow challenges and competitive pressures require careful monitoring.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
